100
Participants
Start Date
October 6, 2023
Primary Completion Date
September 30, 2024
Study Completion Date
December 15, 2024
Screening
Patients are screened to confirm they are low risk for a penicillin allergy
Low dose Penicillin
Low risk participants are given a low-dose of oral penicillin followed by 60 minutes of observation
Standard dose Penicillin
Participants who have taken the low dose of oral penicillin and have had no reaction are provided a second higher dose of penicillin (250mg) and observed for 60 minutes.
Remove allergy label
Participants who have no reaction after 28 days have their penicillin allergy label removed from their electronic medical record and hospital record.
RECRUITING
Muskoka Algonquin Healthcare, Huntsville
Northern Ontario School of Medicine
OTHER